China coronavirus vaccine may be ready for public in November

Coronavirus Vaccine latest: The Coronavirus vaccine could be available in the United States before the end of this year, claimed American pharmaceutical company Pfizer CEO Albert Bourla.

In that regard, Siegel said Bourla told the Food and Drug Administration that 44,000 people will be part of a vaccine test - meaning 22,000 get the vaccine and 22,000 do not.

"In our best case we have quite a good chance - more than 60% - but we will know if the product works or not by the end of October", Bourla said in a recent interview.

How many COVID-19 cases were recorded in B.C
The increase of 1,151 cases across the state reported Tuesday was led by two counties: Centre County and Philadelphia County . The news comes on the same day that the county saw 73 new positive cases of COVID-19, raising that total to 29,519.

"This new agreement could help us vaccinate millions of people across the country, as well as help create a United Kingdom vaccine manufacturing facility to speed up access to a potential Covid-19 candidate and boost the country's resilience against future pandemics", said Britain's Business Secretary Alok Sharma.

The World Health Organization has cited AZD1222, replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus which contains the genetic material of the SARS-CoV-2 virus spike protein, as a leading contender in the race for a vaccine. Answering a question whether Pfizer-BioNTech could get the FDA to approve it as safe and distribute it across to the USA before the end of 2021, Bourla said, "I cannot say what the FDA will do. I think this is a very promising situation".

Sinopharm said in July that its vaccine could be ready for public use by the end of this year after the conclusion of Phase 3 trials.

EU to delay euro clearing decision on Brexit divorce threat
Johnson's move has dynamited he dwindling trust between Britain and the European Union as they try to negotiate a new trading relationship.

"The proposed expansion would allow the companies to further increase trial population diversity, and include adolescents as young as 16 years of age and people with chronic, stable HIV (human immunodeficiency viruses), Hepatitis C, or Hepatitis B infection, as well as provide additional safety and efficacy data", Pfizer said in a statement.

Britain has struck agreements with a number of pharmaceutical firms developing vaccines against the novel coronavirus in order to ensure it has access to an effective innoculation, including BioNTech, Pfizer, Janssen pharmaceuticals and Novavax.

Northwestern to stay at 9th place in U.S
Kansas State University in Manhattan ranked 170th overall and 83rd among public universities, the report said. The private university also earned the No. 191 spot among schools with the best social mobility.

Latest News